Company Profile

New England Discovery Partners LLC
Profile last edited on: 11/7/17      CAGE: 6KZM0      UEI: NX5KUBB88A21

Business Identifier: Organic synthesis, medicinal chemistry and structure based drug design
Year Founded
2012
First Award
2015
Latest Award
2018
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

23 Business Park Drive
Branford, CT 06405
   (203) 208-2523
   N/A
   www.nedp.com
Location: Single
Congr. District: 03
County: New Haven

Public Profile

New England Discovery Partners (NEDP) is a chemistry contract research organization (CRO) that specializes in synthetic and medicinal chemistry, and structure-based drug design. Our experience, dedication and commitment to quality makes us an ideal partner for discovery stage research. The firm rovides medicinal chemistry, synthetic chemistry and X-ray crystallography services as its core business, and pharmacokinetics, drug metabolism, pharmacology and toxicology through partnering organizations. By combining the experience and resources of multiple organizations, each with a long track record of success in their respective areas, NEDP can deliver a full range of drug discovery services to meet the needs of clients.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2018 2 NIH $593,950
Project Title: Targeting STT3A and STT3B to Block Flavivirus Replication
2015 1 NIH $224,015
Project Title: Small Molecule Inhibitors of Group Ii Introns for Treatment of Fungal Infections

Key People / Management

  G Erik Jagdmann -- Principal Scientist

  Michael Christopher Van Zandt

  Michael C Vanzandt

  Darren Whitehouse -- Principal Scientist

Company News

There are no news available.